September 24, 2020 09:00 - 10:15 EDT
In this five-part series we will bring together expertise from across the firm to cover developments that span the complete lifecycle of this industry’s complex business model—from financing and procurement to regulation and litigation.
Life sciences is one of the most heavily regulated industries in Canada. In this session, partners Teresa Reguly, Yael Bienenstock and Andrew Bernstein discuss the difficulties that can arise from the regulatory environment, including strategies to confront regulatory overreach. The trio will use recent challenges to the Patented Medicines Regulations on administrative and constitutional grounds as a platform to discuss both strategic and practical considerations for life sciences companies.
9:00 a.m. EDT Webinar opens
9:15 - 10:15 a.m. EDT Presentation
Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.
Sessions in this series:
Session 1: Navigating (and challenging) a changing life sciences regulatory environment
Session 2: Life sciences product liability litigation: managing risks and anticipating trends
Session 3: The latest developments in life sciences IP litigation
Session 4: Life sciences and centralized procurement: navigating the process and responding to RFPs
Session 5: Financing life sciences on both sides of the border